A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: The ASSURE study
10.1186/1471-2334-14-289
Saved in:
Main Authors: | Stryjewski M.E., Lentnek A., O'Riordan W., Pullman J., Tambyah P.A., Miró J.M., Fowler Jr. V.G., Barriere S.L., Kitt M.M., Corey G.R. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
BioMed Central Ltd.
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/143213 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Outcomes of Staphylococcus aureus bacteremia
by: PRABHA PARTHASARATHY
Published: (2010) -
Vancomycin monotherapy vs. combination therapy for the treatment of persistent methicillinresistant staphylococcus aureus bacteremia
by: Seah, J., et al.
Published: (2014) -
Vibrio bacteremia in Siriraj Hospital.
by: V. Thamlikitkul
Published: (2018) -
Eubacterium bacteremia and colon cancer
by: Somnuek Sungkanuparph, et al.
Published: (2018) -
Ascension is assured
by: La Viña, Antonio Gabriel M.
Published: (2022)